Home
This Title All WIREs
WIREs RSS Feed
How to cite this WIREs title:
WIREs Nanomed Nanobiotechnol
Impact Factor: 6.14

Recent advances in stealth coating of nanoparticle drug delivery systems

Full article on Wiley Online Library:   HTML PDF

Can't access this content? Tell your librarian.

Abstract Modifying surfaces of nanoparticles (NPs) with polyethylene glycol (PEG), the so‐called PEGylation, is the most commonly used method for reducing premature clearance of NPs from the circulation. However, several reports point out that PEGylation may negatively influence the performance of NPs as a drug carrier. Alternative surface modification strategies, including substitute polymers, conditional removal of PEG, and biomimetic surface modification, may provide solutions for the limitations of PEG. WIREs Nanomed Nanobiotechnol 2012, 4:219–233. doi: 10.1002/wnan.1157 This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease

This WIREs title offers downloadable PowerPoint presentations of figures for non-profit, educational use, provided the content is not modified and full credit is given to the author and publication.

Download a PowerPoint presentation of all images


(a) Polyethylene glycol (PEG) structure; (b) model of PEGylated nanoparticles (NPs).

[ Normal View | Magnified View ]

DePEGylation of NPs by cellular cues.

[ Normal View | Magnified View ]

Poly(hydroxymethylethylene hydroxymethylformal).

[ Normal View | Magnified View ]

Structures of chitosan, heparin, and dextran.

[ Normal View | Magnified View ]

Structure of hyperbranched polyglycerol.127

[ Normal View | Magnified View ]

Structures of poly(sulfobetaine) and poly(carboxybetaine).

[ Normal View | Magnified View ]

Structures of poly(2‐ethyl‐2‐oxazoline), poly(hydroxyethyl‐l‐asparagine) (PHEA), and N‐(2‐hydroxypropyl)methacrylamide (HPMA).

[ Normal View | Magnified View ]

Schematic description of NP‐based drug delivery to tumors. Arrows indicate steps negatively influenced by PEG layer on NP surface.

[ Normal View | Magnified View ]

Related Articles

Nanoparticle therapeutics: a personal perspective
Drug Discovery: An Interdisciplinary View

Browse by Topic

Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease

Access to this WIREs title is by subscription only.

Recommend to Your
Librarian Now!

The latest WIREs articles in your inbox

Sign Up for Article Alerts